- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03392727
Evaluation of Safe Sleep for Babies: a Bassinet Distribution and Education Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed study is a randomized controlled trial with two arms: the intervention group (n=110) will be provided a baby box and standardized face to face education regarding the box and its contents, safe sleep, and infant health promotion; the control group (n=110) will be provided information on how to obtain the same baby box at a community site in Winnipeg, and will receive a safe sleep pamphlet, baby box pamphlet and a guide to online resources for prenatal ad infant health promotion. An additional comparison group will be parents who already have a baby box at the time of recruitment. This group will also receive the safe sleep pamphlet. Families will be interviewed at recruitment and 2-4 months of age to measure box ownership and self-reported safe sleep and infant health promotion practices. Administrative data will be used to evaluate the impact on infant immunizations and hospitalizations in the first year of life, and to evaluate the impacts of prenatal care visits and neonatal length of stay on the outcomes.
Families will be asked to participate in a face to face interview at baseline (enrolment) and one follow-up interview coordinated with a scheduled routine healthcare visit for the infant at 2 months of age and conducted face to face or by telephone, according to family preference.
PHIN will be requested for both mother and infant in order to explore the relationship between adequacy of prenatal care and the study outcomes, and to evaluate the impact on infant immunizations and hospitalizations in the first year of life. Postal code will be requested to analyze differences related to place of residence and neighbourhood income quintile.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P5
- University of Manitoba
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mothers who are 32 weeks or more gestation
- Infants less than 3 months of age (or post-conceptional age 44 weeks)
- Able to consent freely and complete face to face and/or telephone interviews in English
- Will be residing in Winnipeg until the infant is 2-4 months of age or able to complete a telephone interview at 2-4 months of age
Exclusion Criteria:
- Parent/guardian/client less than 18 years of age (unless emancipated minor)
- Parents who cannot consent due to intellectual capacity, medical condition, etc.
- Infant is discharged from hospital in the care of Child and Family Services or a birth alert is in place
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study Box & Education Session
Parents are provided a baby box and infant health and safety products and participate in a face to face educational session
|
Baby box (bassinet) with infant items
Face to face education and baby box orientation session
|
|
Active Comparator: Community Box & Online Education
Parents are informed how to receive a free box from a community site and are provided a guide to online resources for prenatal and infant health promotion
|
Baby box (bassinet)
Online baby box education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Box ownership
Time Frame: 2 months
|
Parents with a baby box
|
2 months
|
|
Usual sleep location
Time Frame: 2 months
|
crib, cradle, bassinet, box, other
|
2 months
|
|
Baby box use for sleep
Time Frame: 2 months
|
always/sometimes/never/not applicable
|
2 months
|
|
Usual sleep position
Time Frame: 2 months
|
supine, other
|
2 months
|
|
Usual infant clothing for sleep
Time Frame: 2 months
|
sleeper, sack, swaddled
|
2 months
|
|
Usual bedding
Time Frame: 2 months
|
none, tucked blanket, other
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safe sleep knowledge
Time Frame: 2 months
|
safe sleep location, position, infant clothing, bedding (1 point each)
|
2 months
|
|
Current infant feeding
Time Frame: 2 months
|
breastfeeding, formula feeding, both
|
2 months
|
|
Household smoking
Time Frame: 2 months
|
total number of cigarettes smoked per day in the household
|
2 months
|
|
Vitamin D
Time Frame: 2 months
|
Infant provided daily dose of Vitamin D (always/sometimes/never)
|
2 months
|
|
Immunizations
Time Frame: 12 months
|
Number of infant immunizations in the first year of life
|
12 months
|
|
Prenatal visits
Time Frame: 9 months
|
Number of prenatal visits
|
9 months
|
|
Infant hospitalizations
Time Frame: 12 months
|
Infant hospitalizations in the first year of life (number of hospitalizations, total hospital days, respiratory vs. non-respiratory hospital days)
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse events
Time Frame: 2 months
|
Parent-reported adverse events and concerns regarding the baby box
|
2 months
|
|
Parent feedback
Time Frame: 2 months
|
Parent-reported opinions and preferences (likes/dislikes) regarding the baby box and the distribution process
|
2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nathan Nickel, PhD, University of Manitoba
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2017:390
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.